Weight Loss Injections Before and After: What the Evidence Actually Shows

What do people actually experience in the first weeks of treatment?

The most common experience in weeks one to four is a noticeable reduction in appetite rather than dramatic weight loss. The starting dose of tirzepatide is 2.5mg, a level chosen specifically to let the body adjust, not to deliver the full therapeutic effect. Semaglutide follows a similar graduated path. Nausea, indigestion and some fatigue are common early on, often settling within days to two weeks. The NHS medicines page for tirzepatide lists these gastrointestinal effects alongside the full side-effect profile, and it is worth reading before you start.

Most people report that food simply becomes less interesting. Portions feel satisfying with less on the plate. This is the biological mechanism working, not willpower. If you want a sense of what that shift looks like in practice, you can browse before and after pictures from people using weight loss injections, which show how results tend to build gradually across the weeks rather than arriving all at once.

Our overview of how weight loss injections work goes into the mechanism in more detail if the biology is useful context.

How much weight loss do the trials actually show, and what changes beyond the scales?

SURMOUNT-1, the pivotal trial for tirzepatide, randomised 2,539 adults with obesity over 72 weeks. At the highest dose, participants lost an average of around 20–21% of their body weight. The STEP 1 trial for semaglutide 2.4mg, run over 68 weeks, found an average reduction of approximately 15%. These are averages across large populations; individual results sit both above and below those figures. The SURMOUNT-1 paper published in the New England Journal of Medicine gives the full breakdown if you want the primary data.

Beyond the number on the scales, participants in both programmes also reported improvements in blood pressure, cholesterol, blood sugar and (for many) sleep quality and joint comfort. A 15–20% reduction in body weight is clinically significant. For someone starting at 100kg, that is 15–20kg. The physical before-and-after is real, but so are the metabolic changes running alongside it.

If you are thinking about what results look like across different weight loss injections in the UK, that page covers the evidence side by side.

When do results typically plateau, and what affects the timeline?

Weight loss tends to be fastest in the first three to six months, after which the rate slows as the body adjusts to a lower set point. Most of the trial results cited above were measured at 68 or 72 weeks, reflecting that this is a sustained process rather than a rapid one. Dose titration plays a significant role: moving from a starting dose to a maintenance dose (managed by a prescriber in response to how you are tolerating treatment) is what drives the deeper results.

Other factors that influence how the before-and-after compares in practice: how closely a reduced-calorie diet is followed, protein intake (important to protect muscle as weight falls), hydration, and whether regular physical activity is built into the routine. None of these replace the medicine, and the medicine does not replace them. The weekly injection options for weight management page covers eligibility criteria that shape who can access these treatments privately.

One thing our prescribers hear fairly regularly: people are surprised by how much of the change happens between week twelve and week thirty-six, after the initial excitement of early loss. Patience after the first dose increase (sometimes landing around the time you are juggling a busy week) matters more than people expect.

What happens to results if you stop treatment?

This is one of the most searched questions alongside before-and-after queries, and it deserves a direct answer. Research consistently shows that stopping GLP-1 treatment leads to partial weight regain in many people, because the hormonal signals that reduced appetite are no longer present. The evidence on weight regain after stopping weight loss injections looks at this in detail. It is not universal, and lifestyle changes embedded during treatment can buffer the effect, but it is not uncommon either.

This does not mean the treatment has failed. It reflects the biology of weight regulation. The clinical picture at one year looks different to the picture at three months, and long-term plans are something a prescriber should be involved in at each repeat review. At nume, every repeat order goes through fresh clinical re-review, there are no automatic renewals. For anyone thinking about the cost implications of longer-term treatment, the context on what weight loss injection pricing includes is worth reading before comparing providers.

If you are ready to talk through whether treatment is suitable for your situation, you can speak to our prescribers via a free consultation. It is reviewed the same day by a real clinician, not automated software.